세계의 연구용 단백질 시장

Global Research-Grade Proteins Market to Reach US$2.0 Billion by 2030

The global market for Research-Grade Proteins estimated at US$1.0 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 12.4% over the analysis period 2024-2030. Cytokines & Growth Factors, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$683.0 Million by the end of the analysis period. Growth in the Antibodies segment is estimated at 9.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$265.7 Million While China is Forecast to Grow at 11.6% CAGR

The Research-Grade Proteins market in the U.S. is estimated at US$265.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$316.6 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.7% and 10.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.

Global Research-Grade Proteins Market - Key Trends & Drivers Summarized

Why Are Research-Grade Proteins Essential in Scientific and Biopharmaceutical Advancements?

Research-grade proteins play a fundamental role in biotechnology, pharmaceutical research, and life sciences, serving as key components in drug development, molecular biology, and diagnostic applications. These highly purified proteins are used extensively in academic and commercial research labs for studying protein functions, interactions, and structures. The increasing focus on precision medicine and biologic drug discovery has driven demand for research-grade proteins, particularly in proteomics, cell culture studies, and enzyme-linked immunosorbent assays (ELISAs). With the rise of recombinant protein production and advancements in protein engineering, researchers now have access to more stable, scalable, and high-quality proteins for experimental use. The ongoing expansion of the biopharmaceutical sector and growing investments in research and development (R&D) have further propelled the need for reliable, research-grade protein solutions.

How Are Technological Innovations Enhancing Research-Grade Protein Production?

The development of recombinant DNA technology has significantly improved the production of research-grade proteins, enabling scientists to express and purify proteins in microbial, mammalian, and insect cell systems with high yield and specificity. The integration of CRISPR-based genome editing techniques has also enhanced protein expression and functionality, providing researchers with precise tools to study gene regulation and protein interactions. Additionally, advancements in protein purification methods, such as affinity chromatography and mass spectrometry-based characterization, have improved the consistency and reproducibility of research-grade protein products. The adoption of artificial intelligence (AI) and computational biology in protein design is further accelerating protein engineering, allowing for the development of novel protein variants with enhanced stability and therapeutic potential. These innovations are ensuring that research-grade proteins meet the stringent quality and purity requirements of modern scientific applications.

What Market Trends Are Driving the Demand for Research-Grade Proteins?

The increasing use of protein-based assays in drug screening and biomarker discovery has been a significant factor driving the demand for research-grade proteins. The expansion of personalized medicine and the growing interest in cell and gene therapies have further fueled the need for high-quality protein reagents in research. Additionally, the rise of high-throughput screening techniques and automation in life sciences laboratories has created a demand for standardized, reproducible protein products. Pharmaceutical companies and contract research organizations (CROs) are investing heavily in research-grade proteins to accelerate drug discovery pipelines, particularly for monoclonal antibodies and recombinant biologics. The increasing availability of custom protein expression and purification services is also expanding the market, allowing researchers to access specialized proteins tailored to their experimental needs.

What Are the Key Growth Drivers of the Research-Grade Proteins Market?

The growth in the global research-grade proteins market is driven by increasing R&D investments in biopharmaceuticals, advancements in protein expression technologies, and the rising adoption of protein-based analytical methods. The expansion of proteomics research and the need for high-quality protein reagents in molecular biology have further propelled market demand. Additionally, the growth of personalized medicine and targeted drug development has increased the reliance on recombinant protein technologies. The emergence of AI-powered protein engineering and high-throughput screening platforms is enhancing the efficiency and scalability of protein research. As research institutions and biotech companies continue to explore novel protein-based therapeutics and diagnostics, the demand for research-grade proteins is expected to grow, shaping the future of drug discovery and biomedical innovation.

SCOPE OF STUDY:

The report analyzes the Research-Grade Proteins market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Others); Host Cell (Mammalian Cells, Bacterial Cells, Fungi & Yeast, Insect Cells, Others); End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

• Abcam Plc
• ACROBiosystems
• Anaspec
• Athens Research and Technology
• BioLegend
• Bio-Techne
• BioVision, Inc.
• BPS Bioscience
• Cell Signaling Technology
• Creative BioMart
• Enzo Life Sciences
• GenScript
• GenWay Biotech
• Lifespan Biosciences
• Miltenyi Biotec
• New England Biolabs
• Novoprotein
• OriGene Technologies
• PeproTech (a Thermo Fisher brand)
• ProSpec-Tany Technogene Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Research-Grade Proteins - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Proliferation of Cell Biology and Molecular Research Drives Demand for High-Purity Research-Grade Proteins
  • Increased Investment in Cancer and Neurobiology Studies Strengthens Business Case for Recombinant Proteins
  • Growth in Stem Cell and Organoid Cultures Throws the Spotlight on Protein-Based Culture Supplements
  • Expansion of Protein-Protein Interaction Studies Accelerates Use of Tagged and Labeled Proteins
  • Advancements in Structural Biology and Cryo-EM Drive Demand for High-Stability Protein Constructs
  • Growth in Immunology and Vaccine Research Generates Demand for Purified Antigens and Cytokines
  • Rising Focus on Reproducibility in Life Sciences Supports Demand for cGMP-Aligned Research Reagents
  • Integration of AI-Based Protein Modeling Enhances Demand for Custom Engineered Proteins
  • Surge in Functional Proteomics Applications Supports Expansion of Signaling and Kinase Protein Libraries
  • Adoption of Cell-Free Protein Expression Systems Strengthens Rapid Research-Grade Protein Production
  • Increased Use in CRISPR and Gene Editing Workflows Fuels Market for Nucleases and Ligases
  • Collaborations Between Academic Labs and Biotech Firms Support Custom Protein Manufacturing
  • Shift Toward Serum-Free and Chemically Defined Media Expands Market for Recombinant Cell Culture Proteins
  • Demand for Fluorescently Labeled and Affinity-Purified Proteins Grows in Imaging and Screening Applications
  • Global Expansion of Bioresearch Infrastructure Enhances Access to High-Quality Protein Suppliers
  • Standardization of Protein Characterization Techniques Enhances Quality Benchmarks in Research Use
  • Rapid Growth of Biomarker Discovery and Translational Research Fuels Demand for Diagnostic-Grade Proteins
  • Ethical Sourcing and Elimination of Animal-Origin Products Strengthen Market for Recombinant Alternatives
  • Growth in Personalized Research Models Using iPSC and Patient-Derived Cells Increases Need for Specialized Proteins
  • Use of Research-Grade Proteins in High-Throughput Assays and Automation Platforms Propels Volume Demand
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Research-Grade Proteins Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Research-Grade Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Research-Grade Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Cytokines & Growth Factors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Cytokines & Growth Factors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Immune Checkpoint Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Immune Checkpoint Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Virus Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Virus Antigens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Recombinant Regulatory Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Recombinant Regulatory Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Hormones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World 6-Year Perspective for Hormones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 19: World 6-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Bacterial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World 6-Year Perspective for Bacterial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Fungi & Yeast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World 6-Year Perspective for Fungi & Yeast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 24: World Recent Past, Current & Future Analysis for Insect Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 25: World 6-Year Perspective for Insect Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Host Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World 6-Year Perspective for Other Host Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Mammalian Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 29: World 6-Year Perspective for Mammalian Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 30: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 31: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 35: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 36: USA Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 37: USA 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 40: USA Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 41: USA 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• CANADA
  • TABLE 42: Canada Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 43: Canada 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 46: Canada Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Canada 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• JAPAN
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 48: Japan Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 49: Japan 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 52: Japan Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 53: Japan 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• CHINA
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 54: China Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 55: China 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 58: China Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 59: China 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• EUROPE
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 60: Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 61: Europe 6-Year Perspective for Research-Grade Proteins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 64: Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 65: Europe 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 66: Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 67: Europe 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• FRANCE
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 68: France Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: France 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 70: France Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 71: France 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 72: France Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 73: France 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• GERMANY
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 74: Germany Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Germany 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 76: Germany Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 77: Germany 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 78: Germany Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 79: Germany 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• ITALY
  • TABLE 80: Italy Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Italy 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 82: Italy Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 83: Italy 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 84: Italy Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 85: Italy 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• UNITED KINGDOM
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 86: UK Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: UK 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 88: UK Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 89: UK 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 90: UK Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 91: UK 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Europe 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 95: Rest of Europe 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 97: Rest of Europe 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• ASIA-PACIFIC
  • Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 101: Asia-Pacific 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 103: Asia-Pacific 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Rest of World 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030
  • TABLE 106: Rest of World Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 107: Rest of World 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030
  • TABLE 108: Rest of World Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 109: Rest of World 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION